November 13, 2020
We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]
October 9, 2020
Pharmazac launches Zaolin, the first generic vinorelbin for oral use (soft caps) in Greece. Zaolin is a chemotherapy drug used to treat non-small cell lung cancer […]
September 7, 2020
Sugammadex is an intravenous medication given by doctors to rapidly reverse muscle relaxation caused by drugs like rocuronium and vecuronium after surgery. Pharmazac launches the 1st […]
April 10, 2019
Pharmazac launches the new product Apregalin® (pregabalin) for the treatment of peripheral and central neuropathic pain in adults, for epilepsy as adjunctive therapy in adults with […]
April 10, 2019
Pharmazac has just launched the new product Vasitimb (ezetimibe + simvastatin) for the prevention of cardiovascular events, for hypercholesterlaemia and the Homozygous Familial Hypercholesterolaemia. Vasitimb is indicated […]
October 17, 2018
Pharmazac has enriched its product portfolio with the new brand Calcium Folinate/Pharmazac, an injectable solution 200mg/20ml Bt x 1 vial x20ml for intravenous or intramuscular use. Calcium Folinate/Pharmazac is the […]
August 29, 2018
Pharmazac launches Abelfiz (aripiprazole) in 10mg, 15mg and 30mg hard tablets for the treatment of schizophrenia in adults and adolescents aged 15 years and older. Abelfiz […]
May 25, 2018
Pharmazac announces that its state-of-the-art Research and Development Lab at its headquarters received by the Greek Ministry of Health a GMP manufacturing license (clinical batches) for […]
February 14, 2018
